BioCentury
ARTICLE | Company News

Ariad, Eli Lilly musculoskeletal, infectious news

August 31, 2009 7:00 AM UTC

The U.S. Court of Appeals for the Federal Circuit agreed to rehear en banc a suit brought by Ariad against Eli Lilly. By reinstating the appeal, the CAFC vacated its April 3 ruling that Eli Lilly's os...